EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer

Feiyu Bai, Leen Liao, Yuanling Tang, Yihang Wu, Zhangjie Wang, Hengyu Zhao, Jingming Huang, Xin Wang, Peirong Ding, Xiaojian Wu, Zerong Cai

Cancer Letters · 2025-09 · 628 · 217871

DOI: 10.1016/j.canlet.2025.217871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025-09. Verfasst von Feiyu Bai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong, China; Guangdong Provincial Key…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Magnetic Resonance Imaging, Machine Learning. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sun Yat-sen University, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoadjuvant therapy (NAT) is the standard treatment strategy for MRI-defined cT4 rectal cancer. Predicting tumor regression can guide the resection plane to some extent. Here, we covered pre-treatment MRI imaging of 363 cT4 rectal cancer patients receiving NAT and radical surgery from three hospitals: Center 1 (n = 205), Center 2 (n = 109) and Center 3 (n = 52). We propose a machine learning model named RCMIX, which incorporates a multilayer perceptron algorithm based on 19 pre-treatment MRI radiomic features and 2 clinical features in cT4 rectal cancer patients receiving NAT. The model was trained on 205 cases of cT4 rectal cancer patients, achieving an AUC of 0.903 (95 % confidence interval, 0.861-0.944) in predicting T-downstage. It also achieved AUC of 0.787 (0.699-0.874) and 0.773 (0.646-0.901) in two independent test cohorts, respectively. cT4 rectal cancer patients who were predicted as Well T-downstage by the RCMIX model had significantly better disease-free survival than those predicted as Poor T-downstage. Our study suggests that the RCMIX model demonstrates satisfactory performance in predicting T-downstage by NAT for cT4 rectal cancer patients, which may provide critical insights to improve surgical strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsMagnetic Resonance ImagingMachine LearningHumansFemaleMaleNeoadjuvant TherapyNeoplasm StagingMiddle AgedAgedRetrospective StudiesDisease-Free SurvivalAdultPrognosis

Stichwörter der Autor:innen

MRI imagingMultilayer perceptronRadiomicsT-downstagecT4 rectal cancer

Autor:innen und Institutionen

  • Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affilia…
  • Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangdong, China.
  • Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Sichuan, China; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Sich…
  • Department of Information Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong, China.
  • Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangdong, China. Electronic address: di…

Förderung

  • Sun Yat-sen University
  • Guangzhou Municipal Science and Technology Project

Zitieren

APA

Bai, F., Liao, L., Tang, Y., Wu, Y., Wang, Z., Zhao, H., Huang, J., Wang, X., Ding, P., Wu, X., & Cai, Z. (2025). RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer. Cancer Letters, 628, 217871. https://doi.org/10.1016/j.canlet.2025.217871

Vancouver

Bai F, Liao L, Tang Y, Wu Y, Wang Z, Zhao H, et al. RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer. Cancer Letters. 2025;628:217871. doi:10.1016/j.canlet.2025.217871

BibTeX
@article{Bai2025,
  author = {Bai, Feiyu and Liao, Leen and Tang, Yuanling and Wu, Yihang and Wang, Zhangjie and Zhao, Hengyu and Huang, Jingming and Wang, Xin and Ding, Peirong and Wu, Xiaojian and Cai, Zerong},
  title = {RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer},
  journal = {Cancer Letters},
  year = {2025},
  volume = {628},
  pages = {217871},
  doi = {10.1016/j.canlet.2025.217871}
}
Kostenlos starten →